Gene Im, MD
- ASSISTANT PROFESSOR | Medicine, Liver Diseases
Specialties:Liver Medicine, Liver Transplantation
Research Topics:Hepatitis C Virus, Liver, Transplantation
Dr. Gene Y Im is an Assistant Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai. He earned his B.A. from the University of California, Berkeley, graduating with honors. He completed his Internal Medicine residency and fellowship in Gastroenterology at Winthrop-University Hospital, the primary teaching affiliate for the SUNY Stony Brook School of Medicine. He then completed an advanced fellowship in Transplant Hepatology at the Mount Sinai Medical Center. He is currently the Associate Program Director of the Transplant Hepatology fellowship and RSS course director of the Division of Liver Diseases at Mount Sinai.
Dr. Im’s areas of clinical interest include cirrhosis, acute/chronic liver diseases, portal hypertension, liver biopsy, quality improvement, endoscopy, inpatient care of liver patients and liver transplantation.
His research program focuses on alcoholic hepatitis and liver disease, including early liver transplantation for alcoholic hepatitis, portal hypertension, liver biopsy and outcomes-based research.
Dr. Im is an UNOS-certified Liver Transplant physician and is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. He is also a member of the American Association for the Study of Liver Diseases.
American Board of Internal Medicine
- Colon Polypectomy
- Endoscopic Band Ligation
- Esophageal Varices
- Flexible Sigmoidoscopy
MD, New York Medical College
Residency, Internal Medicine, Winthrop University Hospital
Fellowship, Gastroenterology, Winthrop University Hospital
Fellowship, Transplant Hepatology, Mount Sinai School of Medicine
Emerging Therapies for Severe Alcoholic Hepatitis
Early liver transplantation for severe alcoholic hepatitis has recently been demonstrated to be a feasible and effective therapy for highly selected patients who fail medical therapy and violate the so-called “6 month rule,” using a rigorous evaluation program. Here at Mount Sinai, we are leading the North American experience of early liver transplantation as a rescue therapy for selected patients with severe alcoholic hepatitis. Particular areas of interest include patient selection, outcomes, burden on organ supply and alcohol relapse. Translational collaborations are being planned with the Alcoholic Liver Disease Research Center at Mount Sinai to further elucidate the pathogenesis of alcoholic hepatitis. Future clinical trials to evaluate therapies with less side-effects, more targeted therapies or those aimed hepatic regeneration are needed.
Outcomes of Inpatient Hospital Transfers to a Liver Transplant Center
The purpose of this study is to examine the characteristics and outcomes of patients referred for inpatient hospital transfer to Mount Sinai Medical Center. These patients anecdotally have poor clinical outcomes, but a systematic evaluation of this special population has not been performed. Multivariate analysis demonstrated that patients with acute on chronic liver failure were more likely to have inpatient mortality. Future efforts will focus on a cost analysis of inpatient hospital transfers to the liver service.
Im GY. Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience.. Am J Transplant 2016; 16(3): 841-849.
Im GY, Sehgal V, Ward SC. A case of undulating fevers and elevated liver tests after pancreas-kidney transplantation. Seminars in liver disease 2013 Feb; 33(1).
Leong J, Im GY. Evaluation and selection of the patient with alcoholic liver disease for liver transplant. Clinics in liver disease 2012 Nov; 16(4).
Im GY, Kazi S, Thung SN, Perumalswami PV. A maxed-out liver: a case of acute-on-chronic liver failure. Seminars in liver disease 2011 Nov; 31(4).
Stavropoulos SN, Im GY, Jlayer Z, Harris MD, Pitea TC, Turi GK, Malet PF, Friedel DM, Grendell JH. High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction. Gastrointestinal endoscopy 2012 Feb; 75(2).
Im GY, Modayil RJ, Lin CT, Geier SJ, Katz DS, Feuerman M, Grendell JH. The appendix may protect against Clostridium difficile recurrence. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011 Dec; 9(12).
Im GY, Stavropoulos SN, Schrope BA. An unusual cause of pancreatitis. Gastroenterology 2011 Dec; 141(6).